Development and validation of nomogram for predicting the cancer‐specific survival among patients aged 80 and above with early‐stage non‐small cell lung cancer

We have successfully created a highly accurate and discriminative nomogram that enables oncologists to predict the survival outcome of each individual patient with I/II NSCLC who is 80 years or older.